Galectin Therapeutics
GALT
#8192
Rank
C$0.23 B
Marketcap
$3.81
Share price
-3.37%
Change (1 day)
42.44%
Change (1 year)

EPS for Galectin Therapeutics (GALT)

EPS in 2023 (TTM): -$0.89

According to Galectin Therapeutics's latest financial reports the company's current EPS (TTM) is -$0.92. In 2022 the company made an earnings per share (EPS) of -$0.91 a decrease over its 2021 EPS that were of -$0.73.

EPS history for Galectin Therapeutics from 2002 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$0.89-1.99%
2022-$0.9125%
2021-$0.7330%
2020-$0.56-6.98%
2019-$0.6013.16%
2018-$0.53-22.45%
2017-$0.69-35.53%
2016-$1.06-13.64%
2015-$1.2311.39%
2014-$1.11-39.69%
2013-$1.8381.94%
2012-$1.01-32.08%
2011-$1.487.07%
2010-$1.39-17.5%
2009-$1.68150%
2008-$0.67-68%
2007-$2.10127.27%
2006-$0.92-52.17%
2005-$1.93-20.69%
2004-$2.4352.63%
2003-$1.59-13.64%
2002-$1.85

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$17.94 1,842.42%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.27-71.21%๐Ÿ‡บ๐Ÿ‡ธ USA